- Home
- INTS vs MODD Comparison
INTS vs MODD Comparison
Compare INTS & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- MODD
- Stock Information
- Founded
- INTS 2012
- MODD 1998
- Country
- INTS United States
- MODD United States
- Employees
- INTS N/A
- MODD N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- MODD Industrial Specialties
- Sector
- INTS Health Care
- MODD Health Care
- Exchange
- INTS Nasdaq
- MODD Nasdaq
- Market Cap
- INTS 30.8M
- MODD 35.5M
- IPO Year
- INTS 2023
- MODD N/A
- Fundamental
- Price
- INTS $1.30
- MODD $0.92
- Analyst Decision
- INTS Strong Buy
- MODD
- Analyst Count
- INTS 3
- MODD 0
- Target Price
- INTS $8.50
- MODD N/A
- AVG Volume (30 Days)
- INTS 37.8K
- MODD 122.6K
- Earning Date
- INTS 05-08-2025
- MODD 02-13-2025
- Dividend Yield
- INTS N/A
- MODD N/A
- EPS Growth
- INTS N/A
- MODD N/A
- EPS
- INTS N/A
- MODD N/A
- Revenue
- INTS N/A
- MODD N/A
- Revenue This Year
- INTS N/A
- MODD N/A
- Revenue Next Year
- INTS N/A
- MODD N/A
- P/E Ratio
- INTS N/A
- MODD N/A
- Revenue Growth
- INTS N/A
- MODD N/A
- 52 Week Low
- INTS $1.27
- MODD $0.68
- 52 Week High
- INTS $5.28
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- INTS 22.77
- MODD 48.62
- Support Level
- INTS $1.78
- MODD $0.79
- Resistance Level
- INTS $1.94
- MODD $0.95
- Average True Range (ATR)
- INTS 0.17
- MODD 0.10
- MACD
- INTS -0.03
- MODD 0.00
- Stochastic Oscillator
- INTS 4.10
- MODD 55.12
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.